An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
NCT05295433
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Methylmalonic Acidemia
Interventions
DRUG:
mRNA-3705
Sponsor
ModernaTX, Inc.